Articles

Properdin
September 01 2005  by Dr. Lars Otto Uttenthal

Properdin

Properdin is an important complement factor, essential for the functioning of the alternative activation pathway. Properdin deficiency, an X-linked recessive trait, has been regarded as rare. It is associated with a very high susceptibility to meningococcal disease. In certain categories of patients with meningococcal disease, the frequency of properdin deficiency is quite high and concurrent MBL deficiency may put these patients at particularly high risk. It would be advisable to screen these categories for properdin and MBL deficiency and offer meningococcal vaccination in cases of deficiency.

Recent News

AnitbodyShop.com   New tools for cancer research: Plasminogen Activation System antibodies

May 05 2008

BioPorto Diagnostics is happy to announce the launch of a unique group of monoclonal antibodies against components of the Plasminogen Activation System. The antibodies are very well characteri...

AnitbodyShop.com   Product launch - Anti-NGAL (monkey) antibody

April 10 2008

AnitbodyShop.com   The Biomarker World Congress 2008, 19-21 May - Philadelphia, USA

April 10 2008

AnitbodyShop.com   ISICEM, Brussels, Belgium 18-21 March 2008

March 04 2008

AnitbodyShop.com   BioPorto at ToxExpo, Seattle, Washington 16-20 March 2008

February 13 2008

BioPorto - Grusbakken 8, DK-2820 Gentofte, Denmark
Phone: (+45) 4529 0000 - Fax: (+45) 4529 0001 - Email: info@bioporto.com

Created by Wizkids ApShttp://wizkids.dk